Evidence map›Paper›PMID 28454258›Full record

ArticleOncology letters2017

Locally advanced paranasal sinus carcinoma: A study of 30 patients.

Francesco Perri, Raffaele Addeo, Manuel Conson, Adriana Faiella, Giuseppina Della Vittoria Scarpati, Gabriella Torre, Angela Di Biase, Paola Romanelli, Carlo Buonerba, Giuseppe Di Lorenzo and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Francesco PerriMedical Oncology Unit, 'Santissima Annunziata' Hospital, I-74100 Taranto, Italy.
Raffaele AddeoOncology Unit, 'ASL Napoli 2 Nord', San Giovanni di Dio Hospital, I-80027 Naples, Italy.
Manuel ConsonDepartment of Radiation Therapy, University of Naples 'Federico II', I-80131 Naples, Italy.
Adriana FaiellaDepartment of Radiation Therapy, University of Naples 'Federico II', I-80131 Naples, Italy.
Giuseppina Della Vittoria ScarpatiMedical Oncology Unit, 'Santissima Annunziata' Hospital, I-74100 Taranto, Italy.
Gabriella TorreDepartment of Radiation Therapy, University of Naples 'Federico II', I-80131 Naples, Italy.
Angela Di BiaseDepartment of Radiation Therapy, University of Naples 'Federico II', I-80131 Naples, Italy.
Paola RomanelliDepartment of Radiation Therapy, University of Naples 'Federico II', I-80131 Naples, Italy.
Carlo BuonerbaOncological Referral Center of Basilicata, The Institute for Research, Hospitalization and Health Care, Rionero in Vulture, I-85028 Potenza, Italy.
Giuseppe Di LorenzoDepartment of Endocrinology and Molecular and Clinical Oncology, University of Naples 'Federico II', I-80131 Naples, Italy.
Antonio DaponteHead and Neck Medical Oncology Unit, National Tumour Institute of Naples, The Institute for Research, Hospitalization and Health Care 'Fondazione Giovanni Pascale', I-80131 Naples, Italy.
Francesco CaponigroHead and Neck Medical Oncology Unit, National Tumour Institute of Naples, The Institute for Research, Hospitalization and Health Care 'Fondazione Giovanni Pascale', I-80131 Naples, Italy.
Salvatore PiscontiMedical Oncology Unit, 'Santissima Annunziata' Hospital, I-74100 Taranto, Italy.
Roberto PacelliOncology Unit, 'ASL Napoli 2 Nord', San Giovanni di Dio Hospital, I-80027 Naples, Italy.
Vincenzo RavoDepartment of Radiotherapy, The Foundation Institute for Research, Hospitalization and Health Care 'Istituto Nazionale dei Tumori', I-80131 Naples, Italy.
Paolo MutoDepartment of Radiotherapy, The Foundation Institute for Research, Hospitalization and Health Care 'Istituto Nazionale dei Tumori', I-80131 Naples, Italy.
Raffaele SollaInstitute of Biostructure and Bioimaging, National Council of Research, I-80128 Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sinonasal carcinomas (SNcs) are rare neoplasms arising from the paranasal sinuses and nasal cavity. Although these tumours have a heterogeneous histology, they are commonly diagnosed as a locally advanced disease and are associated with a poor prognosis. The present retrospective study reviewed 30 patients with locally advanced SNc, who were treated with surgery followed by chemoradiotherapy or radiotherapy, or radiotherapy with or without concomitant chemotherapy between January 1999 and January 2013 at the Department of Radiation Therapy, University of Naples 'Federico II' (Naples, Italy). A total of 19 patients were treated with upfront surgery followed by adjuvant radio- or chemoradiotherapy (group A), while the remaining 11 patients received exclusive radiotherapy with or without concomitant chemotherapy (group B). Concurrent cisplatin-based chemotherapy (100 mg/m

Indexed as

chemotherapylocally advancednasal cavity tumoursparanasal sinus carcinomaradiotherapythree-dimensional conformal radiotherapy

Identifiers

PMID28454258
PMCPMC5403341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.